Vericel (VCEL) Common Equity (2010 - 2026)
Vericel's Common Equity was $370.04 million in Q2 2026, up 20.6% from $306.81 million a year earlier and up 3.9% from the prior quarter.
Powered by 
Analysis
Vericel (VCEL) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Vericel came in at $354.64 million, up 21.5% from FY2024.
- Common Equity has now increased for eight consecutive years, with a five-year compound annual growth rate of 21.4% (FY2020 to FY2025).
- In earlier years, Common Equity was $291.97 million in FY2024 (+29.2%), $225.95 million in FY2023 (+17.5%), $192.27 million in FY2022 (+12.8%) and $170.46 million in FY2021 (+27.0%).
- The Q2 2026 figure marks the highest quarterly Common Equity in data going back to Q4 2010.
- Compared with a year earlier, Common Equity has increased for 28 straight quarters, with growth averaging 24.4% over the last eight quarters.
- Over the past five years, the year-over-year growth in Common Equity ranged from 12.5% (Q1 2023) to 36.8% (Q3 2021).
- Per Business Quant data, VCEL's Common Equity in the three quarters before Q2 2026 was $356.23 million (Q1 2026), $354.64 million (Q4 2025) and $321.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Vericel | 2.06 Bn | 1.48 Bn | 56.40 Mn | 370.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 370.04 Mn |
| Mar 31, 2026 | 356.23 Mn |
| Dec 31, 2025 | 354.64 Mn |
| Sep 30, 2025 | 321.86 Mn |
| Jun 30, 2025 | 306.81 Mn |
| Mar 31, 2025 | 295.49 Mn |
| Dec 31, 2024 | 291.97 Mn |
| Sep 30, 2024 | 257.47 Mn |
| Jun 30, 2024 | 242.98 Mn |
| Mar 31, 2024 | 233.90 Mn |
| Dec 31, 2023 | 225.95 Mn |
| Sep 30, 2023 | 204.38 Mn |
| Jun 30, 2023 | 198.93 Mn |
| Mar 31, 2023 | 193.98 Mn |
| Dec 31, 2022 | 192.27 Mn |
| Sep 30, 2022 | 177.84 Mn |
| Jun 30, 2022 | 174.82 Mn |
| Mar 31, 2022 | 172.49 Mn |
| Dec 31, 2021 | 170.46 Mn |
| Sep 30, 2021 | 156.78 Mn |
API Access
Vericel Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VCEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VCEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VCEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();